Key Insights
The United States self-monitoring blood glucose (SMBG) market, a significant segment of the broader diabetes care industry, is experiencing robust growth fueled by the rising prevalence of diabetes and increasing awareness of proactive blood sugar management. The market, estimated at $7.62 billion in 2025, is projected to expand at a Compound Annual Growth Rate (CAGR) of 6.40% from 2025 to 2033. This growth is driven by several factors: the increasing diabetic population requiring regular SMBG, technological advancements leading to more accurate and user-friendly devices (like continuous glucose monitors and wireless connected glucometers), and the growing preference for home-based testing. Furthermore, the increasing prevalence of prediabetes, coupled with better healthcare access and insurance coverage for testing supplies, contribute significantly to market expansion. The market segmentation reveals that glucometer devices represent the largest component, followed by test strips and lancets, each contributing substantially to the overall market value. Major players, including Abbott Diabetes Care, Roche Holding AG, LifeScan, and others, are aggressively competing through product innovation, strategic partnerships, and distribution expansion to capture market share.
The competitive landscape is characterized by both established players and emerging companies, each focusing on specific market niches. While larger companies leverage their established brand recognition and extensive distribution networks, smaller players are innovating in areas such as device miniaturization, data connectivity, and personalized diabetes management solutions. However, market growth might be constrained by factors such as the high cost of continuous glucose monitoring systems, potential reimbursement challenges, and the emergence of alternative diabetes management strategies. Nevertheless, the long-term outlook for the US SMBG market remains positive, driven by the persistent increase in diabetes prevalence and the continued development of advanced technologies aimed at improving diabetes management and patient outcomes. The focus will likely shift towards integrated solutions, incorporating data analysis and remote monitoring capabilities to offer personalized and proactive diabetes care.

United States Self-Monitoring Blood Glucose Market Report: 2019-2033
This comprehensive report provides a detailed analysis of the United States Self-Monitoring Blood Glucose (SMBG) market, encompassing its dynamics, growth trends, key players, and future outlook. The report covers the parent market of diabetes care and the child market of SMBG devices and consumables, offering a granular view of this vital sector within the healthcare industry. The study period spans from 2019 to 2033, with 2025 serving as the base and estimated year. The forecast period is 2025-2033, and the historical period covers 2019-2024. The market value is presented in million units.
United States Self-Monitoring Blood Glucose Market Dynamics & Structure
The U.S. SMBG market is characterized by a moderately consolidated structure, with key players like Abbott Diabetes Care, Roche Holding AG, and LifeScan holding significant market share. However, the presence of several smaller players fosters competition and innovation. Technological advancements, particularly in connected devices and data analytics, are driving market growth. Stringent regulatory frameworks, including FDA approvals, influence product development and market entry. The market also faces competition from alternative glucose monitoring methods, such as continuous glucose monitoring (CGM) systems. The aging population and increasing prevalence of diabetes are key demographic drivers. Mergers and acquisitions (M&A) activity remains moderate, with strategic partnerships becoming increasingly prevalent.
- Market Concentration: Moderately consolidated, with top 3 players holding approximately xx% market share (2024).
- Technological Innovation: Focus on connected devices, AI-driven analytics, and improved accuracy.
- Regulatory Landscape: FDA regulations heavily influence product approvals and market access.
- Competitive Substitutes: CGM systems pose a significant competitive threat.
- End-User Demographics: Aging population and rising diabetes prevalence fuel market growth.
- M&A Activity: Moderate M&A activity, with xx deals recorded between 2019 and 2024.
United States Self-Monitoring Blood Glucose Market Growth Trends & Insights
The U.S. SMBG market experienced robust growth between 2019 and 2024, driven by factors such as increasing diabetes prevalence, technological advancements, and rising healthcare expenditure. The market is projected to maintain a steady growth trajectory throughout the forecast period (2025-2033), with a CAGR of xx%. Adoption rates are highest among individuals with type 1 and type 2 diabetes, while technological disruptions, including the integration of mobile apps and cloud connectivity, are transforming user experience and data management. Consumer behavior is shifting towards preference for accurate, convenient, and connected devices.
- Market Size: The market size in 2024 was estimated at xx million units, projected to reach xx million units by 2033.
- CAGR: The projected CAGR for 2025-2033 is xx%.
- Adoption Rates: High adoption rates among individuals with diagnosed diabetes.
- Technological Disruptions: Connected devices and mobile app integration are driving market transformation.
- Consumer Behavior: Demand for user-friendly, accurate, and data-integrated devices is increasing.

Dominant Regions, Countries, or Segments in United States Self-Monitoring Blood Glucose Market
The U.S. SMBG market is geographically widespread, with no single region dominating. However, states with higher diabetes prevalence tend to exhibit stronger market performance. Among components, test strips constitute the largest segment by volume and value, due to their recurring consumption by users. Glucometer devices contribute significantly to the overall market value, while lancets maintain a smaller yet steady market share.
- Leading Segment: Test strips dominate both volume and value, followed by glucometer devices.
- Regional Distribution: Market spread across all states, with higher prevalence areas exhibiting stronger demand.
- Key Drivers: High diabetes prevalence, increased healthcare spending, and improved healthcare access.
United States Self-Monitoring Blood Glucose Market Product Landscape
The SMBG market offers a range of products, from basic glucometers to advanced, connected devices with data-management capabilities. Innovations focus on improving accuracy, ease of use, and integration with other diabetes management tools. Key performance metrics include accuracy, speed of testing, sample size required, and connectivity features. Unique selling propositions (USPs) often center around user experience and data-driven insights.
Key Drivers, Barriers & Challenges in United States Self-Monitoring Blood Glucose Market
Key Drivers: The rising prevalence of diabetes, coupled with technological advancements like connected devices and improved accuracy, significantly drives market growth. Government initiatives promoting diabetes management and increased healthcare spending also contribute positively.
Challenges & Restraints: High costs of SMBG supplies, particularly test strips, can pose a barrier to affordability. Competitive pressure from CGM systems and potential supply chain disruptions are additional challenges. Regulatory hurdles and the need for continuous improvement in device accuracy represent ongoing challenges. The competition from more advanced continuous glucose monitoring (CGM) systems represents a significant threat to the long-term growth of the SMBG market.
Emerging Opportunities in United States Self-Monitoring Blood Glucose Market
Emerging opportunities lie in integrating SMBG devices with telehealth platforms for remote patient monitoring, expanding into underserved populations, and developing personalized diabetes management solutions using data analytics. The focus on user-friendly interfaces and improved data accessibility presents further opportunities. Focus on developing user-friendly applications and integration with other health platforms offer significant growth opportunities.
Growth Accelerators in the United States Self-Monitoring Blood Glucose Market Industry
Technological breakthroughs in sensor technology, improved data analytics, and the development of innovative features such as smart reminders and personalized feedback systems are major growth catalysts. Strategic partnerships between device manufacturers, software developers, and healthcare providers are also accelerating market growth. The expansion into untapped markets through effective marketing and distribution strategies further fuels growth.
Key Players Shaping the United States Self-Monitoring Blood Glucose Market Market
- Rossmax International Ltd
- Abbott Diabetes Care
- Trividia Health
- Acon Laboratories Inc
- Agamatrix Inc
- Bionime Corporation
- LifeScan
- Other Company Share Analyse
- Roche Holding AG
- Ascensia Diabetes Care
- Arkray Inc
Notable Milestones in United States Self-Monitoring Blood Glucose Market Sector
- January 2023: LifeScan publishes real-world data from over 144,000 people demonstrating improved glycemic control using a connected blood glucose meter and mobile app. This significantly boosts the acceptance of connected devices in diabetes management.
- January 20, 2022: Roche launches the COBAS pulse system, a connected point-of-care solution for professional blood glucose management, signifying a shift towards integrated digital solutions.
In-Depth United States Self-Monitoring Blood Glucose Market Market Outlook
The U.S. SMBG market is poised for continued growth driven by technological innovations, increased diabetes awareness, and expanding access to healthcare. Strategic partnerships, focus on data analytics, and the integration of SMBG with other diabetes management tools present significant opportunities for market expansion and value creation in the coming years. The market will see increased competition from CGM, but the affordability and widespread availability of SMBG systems will ensure its continued presence in the market.
United States Self-Monitoring Blood Glucose Market Segmentation
-
1. Component (Value and Volume, 2017 - 2028)
- 1.1. Glucometer Devices
- 1.2. Test Strips
- 1.3. Lancets
United States Self-Monitoring Blood Glucose Market Segmentation By Geography
- 1. United States

United States Self-Monitoring Blood Glucose Market REPORT HIGHLIGHTS
Aspects | Details |
---|---|
Study Period | 2019-2033 |
Base Year | 2024 |
Estimated Year | 2025 |
Forecast Period | 2025-2033 |
Historical Period | 2019-2024 |
Growth Rate | CAGR of 6.40% from 2019-2033 |
Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Rising Prevalence of Cancer Worldwide; Technological Advancements in Diagnostic Testing; Increasing Demand for Point-of-care Treatment
- 3.3. Market Restrains
- 3.3.1. High Cost of Molecular Diagnostic Tests; Lack of Skilled Workforce and Stringent Regulatory Framework
- 3.4. Market Trends
- 3.4.1. Rising Diabetes Prevalence in the United States
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. United States Self-Monitoring Blood Glucose Market Analysis, Insights and Forecast, 2019-2031
- 5.1. Market Analysis, Insights and Forecast - by Component (Value and Volume, 2017 - 2028)
- 5.1.1. Glucometer Devices
- 5.1.2. Test Strips
- 5.1.3. Lancets
- 5.2. Market Analysis, Insights and Forecast - by Region
- 5.2.1. United States
- 5.1. Market Analysis, Insights and Forecast - by Component (Value and Volume, 2017 - 2028)
- 6. Europe United States Self-Monitoring Blood Glucose Market Analysis, Insights and Forecast, 2019-2031
- 6.1. Market Analysis, Insights and Forecast - By Country/Sub-region
- 6.1.1. undefined
- 7. Asia-Pacific United States Self-Monitoring Blood Glucose Market Analysis, Insights and Forecast, 2019-2031
- 7.1. Market Analysis, Insights and Forecast - By Country/Sub-region
- 7.1.1. undefined
- 8. North America United States Self-Monitoring Blood Glucose Market Analysis, Insights and Forecast, 2019-2031
- 8.1. Market Analysis, Insights and Forecast - By Country/Sub-region
- 8.1.1. undefined
- 9. Competitive Analysis
- 9.1. Market Share Analysis 2024
- 9.2. Company Profiles
- 9.2.1 Rossmax International Ltd
- 9.2.1.1. Overview
- 9.2.1.2. Products
- 9.2.1.3. SWOT Analysis
- 9.2.1.4. Recent Developments
- 9.2.1.5. Financials (Based on Availability)
- 9.2.2 Abbott Diabetes Care
- 9.2.2.1. Overview
- 9.2.2.2. Products
- 9.2.2.3. SWOT Analysis
- 9.2.2.4. Recent Developments
- 9.2.2.5. Financials (Based on Availability)
- 9.2.3 Trividia Health
- 9.2.3.1. Overview
- 9.2.3.2. Products
- 9.2.3.3. SWOT Analysis
- 9.2.3.4. Recent Developments
- 9.2.3.5. Financials (Based on Availability)
- 9.2.4 Acon Laboratories Inc
- 9.2.4.1. Overview
- 9.2.4.2. Products
- 9.2.4.3. SWOT Analysis
- 9.2.4.4. Recent Developments
- 9.2.4.5. Financials (Based on Availability)
- 9.2.5 Agamatrix Inc
- 9.2.5.1. Overview
- 9.2.5.2. Products
- 9.2.5.3. SWOT Analysis
- 9.2.5.4. Recent Developments
- 9.2.5.5. Financials (Based on Availability)
- 9.2.6 Bionime Corporation
- 9.2.6.1. Overview
- 9.2.6.2. Products
- 9.2.6.3. SWOT Analysis
- 9.2.6.4. Recent Developments
- 9.2.6.5. Financials (Based on Availability)
- 9.2.7 LifeScan
- 9.2.7.1. Overview
- 9.2.7.2. Products
- 9.2.7.3. SWOT Analysis
- 9.2.7.4. Recent Developments
- 9.2.7.5. Financials (Based on Availability)
- 9.2.8 Other Company Share Analyse
- 9.2.8.1. Overview
- 9.2.8.2. Products
- 9.2.8.3. SWOT Analysis
- 9.2.8.4. Recent Developments
- 9.2.8.5. Financials (Based on Availability)
- 9.2.9 Roche Holding AG
- 9.2.9.1. Overview
- 9.2.9.2. Products
- 9.2.9.3. SWOT Analysis
- 9.2.9.4. Recent Developments
- 9.2.9.5. Financials (Based on Availability)
- 9.2.10 Ascensia Diabetes Care
- 9.2.10.1. Overview
- 9.2.10.2. Products
- 9.2.10.3. SWOT Analysis
- 9.2.10.4. Recent Developments
- 9.2.10.5. Financials (Based on Availability)
- 9.2.11 Arkray Inc
- 9.2.11.1. Overview
- 9.2.11.2. Products
- 9.2.11.3. SWOT Analysis
- 9.2.11.4. Recent Developments
- 9.2.11.5. Financials (Based on Availability)
- 9.2.1 Rossmax International Ltd
List of Figures
- Figure 1: United States Self-Monitoring Blood Glucose Market Revenue Breakdown (Million, %) by Product 2024 & 2032
- Figure 2: United States Self-Monitoring Blood Glucose Market Share (%) by Company 2024
List of Tables
- Table 1: United States Self-Monitoring Blood Glucose Market Revenue Million Forecast, by Region 2019 & 2032
- Table 2: United States Self-Monitoring Blood Glucose Market Volume K Unit Forecast, by Region 2019 & 2032
- Table 3: United States Self-Monitoring Blood Glucose Market Revenue Million Forecast, by Component (Value and Volume, 2017 - 2028) 2019 & 2032
- Table 4: United States Self-Monitoring Blood Glucose Market Volume K Unit Forecast, by Component (Value and Volume, 2017 - 2028) 2019 & 2032
- Table 5: United States Self-Monitoring Blood Glucose Market Revenue Million Forecast, by Region 2019 & 2032
- Table 6: United States Self-Monitoring Blood Glucose Market Volume K Unit Forecast, by Region 2019 & 2032
- Table 7: United States Self-Monitoring Blood Glucose Market Revenue Million Forecast, by Country 2019 & 2032
- Table 8: United States Self-Monitoring Blood Glucose Market Volume K Unit Forecast, by Country 2019 & 2032
- Table 9: United States Self-Monitoring Blood Glucose Market Revenue Million Forecast, by Country 2019 & 2032
- Table 10: United States Self-Monitoring Blood Glucose Market Volume K Unit Forecast, by Country 2019 & 2032
- Table 11: United States Self-Monitoring Blood Glucose Market Revenue Million Forecast, by Country 2019 & 2032
- Table 12: United States Self-Monitoring Blood Glucose Market Volume K Unit Forecast, by Country 2019 & 2032
- Table 13: United States Self-Monitoring Blood Glucose Market Revenue Million Forecast, by Component (Value and Volume, 2017 - 2028) 2019 & 2032
- Table 14: United States Self-Monitoring Blood Glucose Market Volume K Unit Forecast, by Component (Value and Volume, 2017 - 2028) 2019 & 2032
- Table 15: United States Self-Monitoring Blood Glucose Market Revenue Million Forecast, by Country 2019 & 2032
- Table 16: United States Self-Monitoring Blood Glucose Market Volume K Unit Forecast, by Country 2019 & 2032
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the United States Self-Monitoring Blood Glucose Market?
The projected CAGR is approximately 6.40%.
2. Which companies are prominent players in the United States Self-Monitoring Blood Glucose Market?
Key companies in the market include Rossmax International Ltd, Abbott Diabetes Care, Trividia Health, Acon Laboratories Inc, Agamatrix Inc, Bionime Corporation, LifeScan, Other Company Share Analyse, Roche Holding AG, Ascensia Diabetes Care, Arkray Inc .
3. What are the main segments of the United States Self-Monitoring Blood Glucose Market?
The market segments include Component (Value and Volume, 2017 - 2028).
4. Can you provide details about the market size?
The market size is estimated to be USD 7.62 Million as of 2022.
5. What are some drivers contributing to market growth?
Rising Prevalence of Cancer Worldwide; Technological Advancements in Diagnostic Testing; Increasing Demand for Point-of-care Treatment.
6. What are the notable trends driving market growth?
Rising Diabetes Prevalence in the United States.
7. Are there any restraints impacting market growth?
High Cost of Molecular Diagnostic Tests; Lack of Skilled Workforce and Stringent Regulatory Framework.
8. Can you provide examples of recent developments in the market?
January, 2023: LifeScan announced that the peer-reviewed Journal of Diabetes Science and Technology published Improved Glycemic Control Using a Bluetooth Connected Blood Glucose Meter and a Mobile Diabetes App: Real-World Evidence From Over 144,000 People With Diabetes, detailing results from a retrospective analysis of real-world data from over 144,000 people with diabetes-one of the largest combined blood glucose meter and mobile diabetes app datasets ever published.
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 3800, USD 4500, and USD 5800 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in Million and volume, measured in K Unit.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "United States Self-Monitoring Blood Glucose Market," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the United States Self-Monitoring Blood Glucose Market report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the United States Self-Monitoring Blood Glucose Market?
To stay informed about further developments, trends, and reports in the United States Self-Monitoring Blood Glucose Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database



Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)

Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations

Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence